Answers are grounded in this paper and cite their sources.
Objective: The purpose of this study was to determine the effects of 6-week consumption of anthocyanin-containing supplement on eye function.Methods: This was a randomized, placebo-controlled, double-blind, parallel-group comparison study involving 32 healthy Japanese adults with eye fatigue after using visual display terminals (VDTs). Subjects were randomly allocated into either the active group (bilberry-derived anthocyanin 43.2 mg per capsule) or placebo group using a random number generator. Subjects consumed either one active or placebo capsule once a day for 6 weeks. The primary outcome measured was the change in percentage of pupillary response pre- and post-VDT use, whereas the secondary outcomes were tear film break-up time, Schirmer's value, muscle hardness, and subjective symptoms. Experimental data was analyzed using Student's t-test, the two-way analysis of covariance, or Mann–Whitney U-test.Results: Each group included 15 subjects in the efficacy analysis. The active group showed a significant improvement in the logarithmic conversion values of the percentage of pupillary response (active group: 0.2 ± 0.4, placebo group: 0.0 ± 0.3; P = 0.043) and pupillary response/near point (active group: 0.1 ± 0.4, placebo group: −0.1 ± 0.3; P = 0.049) pre- and post-VDT use at 6 weeks compared with the placebo group in a subgroup analysis per eye. No adverse events were reported.Conclusions: The consumption of the supplement containing anthocyanins extracted from bilberry for 6 weeks inhibited the decrease in the accommodative function caused by oxidative stress due to VDT use.Trial registration: UMIN-CTR: UMIN000037039.Foundation: BGG Japan Co., Ltd. and Arysta Health and Nutrition Sciences Corp.
No takes yet. Share an insight, caveat, or question.
Sekikawa et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: